BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27910785)

  • 1. Characterization of Cross-Flow Ultrafiltration Fractions from Maitake Medicinal Mushroom, Grifoia frondosa (Agaricomycetes), Reveals Distinct Cytotoxicity in Tumor Cells.
    Sari M; Hambitzer R; Lelley JI; Toepler K; Teusch N; Nickisch-Hartfiel A
    Int J Med Mushrooms; 2016; 18(8):671-680. PubMed ID: 27910785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Flow Ultrafiltration Fractions of a Cold Aqueous Extract of the Shiitake Culinary-Medicinal Mushroom, Lentinus edodes (Agaricomycetes), Exhibit Apoptosis in Tumor Cells.
    Sari M; Toepler K; Nickisch-Hartfiel A; Teusch N; Hambitzer R
    Int J Med Mushrooms; 2018; 20(11):1107-11119. PubMed ID: 30806234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
    Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
    J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumoral Effects of D-Fraction from Grifola Frondosa (Maitake) Mushroom in Breast Cancer.
    Alonso EN; Ferronato MJ; Gandini NA; Fermento ME; Obiol DJ; López Romero A; Arévalo J; Villegas ME; Facchinetti MM; Curino AC
    Nutr Cancer; 2017 Jan; 69(1):29-43. PubMed ID: 27892708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive Ingredients and Medicinal Values of
    Wu JY; Siu KC; Geng P
    Foods; 2021 Jan; 10(1):. PubMed ID: 33466429
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunomodulating activities of cultivated maitake medicinal mushroom Grifola frondosa (Dicks.: Fr.) S.F. Gray (higher Basidiomycetes) on peripheral blood mononuclear cells.
    Svagelj M; Berovic M; Gregori A; Wraber B; Simcic S; Boh B
    Int J Med Mushrooms; 2012; 14(4):377-83. PubMed ID: 23510175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic immuno-modulatory activity in human macrophages of a medicinal mushroom formulation consisting of Reishi, Shiitake and Maitake.
    Mallard B; Leach DN; Wohlmuth H; Tiralongo J
    PLoS One; 2019; 14(11):e0224740. PubMed ID: 31697749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A (1→6)-Branched (1→4)-β-d-Glucan from
    Su CH; Lu MK; Lu TJ; Lai MN; Ng LT
    J Nat Prod; 2020 Feb; 83(2):231-242. PubMed ID: 31967822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
    Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
    Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Birch Bracket Medicinal Mushroom, Fomitopsis betulina (Agaricomycetes) - Bioactive Source for Beta-Glucan Fraction with Tumor Cell Migration Blocking Ability.
    Sari M; Toepler K; Roth C; Teusch N; Hambitzer R
    Int J Med Mushrooms; 2020; 22(1):1-13. PubMed ID: 32463994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.
    Roldan-Deamicis A; Alonso E; Brie B; Braico DA; Balogh GA
    Cancer Med; 2016 Sep; 5(9):2427-41. PubMed ID: 27401257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Elucidation and Immune-Enhancing Effects of Novel Polysaccharide from
    Seo YR; Patel DK; Shin WC; Sim WS; Lee OH; Lim KT
    Biomed Res Int; 2019; 2019():7528609. PubMed ID: 31139649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential growth inhibitory effect of maitake D-fraction on canine cancer cells.
    Konno S
    Vet Ther; 2004; 5(4):263-71. PubMed ID: 15719326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maitake extracts and their therapeutic potential.
    Mayell M
    Altern Med Rev; 2001 Feb; 6(1):48-60. PubMed ID: 11207456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological activities of the antitumor drug Grifola frondosa polysaccharide.
    He Y; Zhang L; Wang H
    Prog Mol Biol Transl Sci; 2019; 163():221-261. PubMed ID: 31030750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maitake Medicinal Mushroom, Grifola frondosa (Agaricomycetes), and Its Neurotrophic Properties: A Mini-Review.
    Naguib AM; Apparoo Y; Xiong C; Phan CW
    Int J Med Mushrooms; 2023; 25(2):11-22. PubMed ID: 36749053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unambiguous structural elucidation of a 1,3-beta-D-glucan obtained from liquid-cultured Grifola frondosa by solution NMR experiments.
    Tada R; Adachi Y; Ishibashi K; Ohno N
    Carbohydr Res; 2009 Feb; 344(3):400-4. PubMed ID: 19084824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Mushroom-Derived Soluble β-1,6-Glucan Using the Function-Modified Recombinant β-1,6-Glucanase.
    Yamanaka D; Ishibashi KI; Adachi Y; Ohno N
    Int J Med Mushrooms; 2020; 22(9):855-868. PubMed ID: 33389852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Rho1 gene in the cell wall integrity and polysaccharides biosynthesis of the edible mushroom Grifola frondosa.
    Zan XY; Zhu HA; Jiang LH; Liang YY; Sun WJ; Tao TL; Cui FJ
    Int J Biol Macromol; 2020 Dec; 165(Pt A):1593-1603. PubMed ID: 33031851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory properties of Grifola frondosa in submerged culture.
    Wu MJ; Cheng TL; Cheng SY; Lian TW; Wang L; Chiou SY
    J Agric Food Chem; 2006 Apr; 54(8):2906-14. PubMed ID: 16608207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.